A surgical mask next to an open pill bottle that’s toppled over, spilling out red capsules meant to represent vitamin D supplements.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find

The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.

The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.

pandemic
the Melbourne skyline with lake in foreground
New Australian Center Will Develop Therapies for Future Pandemics
Shawna Williams | Aug 31, 2022
Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.
Small vaccine bottles on a conveyer belt
Pfizer and Moderna COVID-19 Omicron Boosters Get OK from the FDA
Catherine Offord | Aug 31, 2022
The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.
Ancient Secrets of the Plague
The Scientist Speaks - Ancient Secrets of the Plague
Niki Spahich, PhD
Simon Rasmussen discusses his research tracking the origins of the plague by analyzing ancient DNA.
Illustration of several warped and stretched analog clocks swirling around a central point.
It’s Not Just You: Lockdowns Had Us Living in “Blursday,” Study Says
Dan Robitzski | Aug 26, 2022
The Scientist spoke with Maximilien Chaumon about his database showing how COVID-19 related lockdowns warped more 2,800 people’s perception of time.
Anthony Fauci
Anthony Fauci Announces Departure from NIAID, Advisory Roles
Catherine Offord | Aug 22, 2022
The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.
Characterizing Proteolysis During SARS-CoV-2 Infection
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
The David J. Sencer Museum at the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia
CDC Restructuring Aims to Improve Timeliness and Accountability
Christie Wilcox | Aug 18, 2022
Director Rochelle Walensky said the agency’s handling of the COVID-19 pandemic fell short and outlined plans to reorganize and strengthen its response to future public health threats.
An illustration of a pregnant women wearing a mask, surrounded by microbes
How COVID-19 Affects Pregnancy
Amanda Heidt | Aug 16, 2022
Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.
Discover new treatments for pandemic diseases
Treatments for Disease Pandemics
The Scientist Creative Services Team
Researchers develop new vaccines and therapeutics to combat the spread of infectious diseases.
A translucent illustration of the BA.2.75 subvariant of SARS-CoV-2 against a black background
Experts Mixed on Risk of “Centaurus” Omicron Subvariant
Dan Robitzski | Aug 15, 2022
BA.2.75 is spreading rampantly in India and has so far reached at least 20 other countries, but it doesn’t seem to be outcompeting other Omicron SARS-CoV-2 subvariants.
Four glass vials sit on a reflective tabletop next to a syringe. Each is labeled as a subsequent dose in a four-dose series of COVID-19 vaccines.
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines
Dan Robitzski | Aug 11, 2022
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
The Impact of Influenza
The Scientist Creative Services Team
Richard Webby and Edward Hutchinson discuss influenza viruses—the development of new strains, how they mediate virulence, and their threat to human society.
Countless bats swarming in the evening dusk
Bat Coronaviruses May Infect Tens of Thousands of People Yearly
Andy Carstens | Aug 10, 2022
Parts of Southeast Asia where human and bat population densities are highest could be infection hotspots, a study finds.
Mosquitos flying at sunset
Climate Change Worsens Most Infectious Diseases
Andy Carstens | Aug 8, 2022
Of the pathogens known to have infected humans, more than half may cause more widespread disease as a result of rising temperatures, precipitation changes, or other climate-related factors, a study finds.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
Man in lab coat looking at the camera and smiling
Can Taking a Test Now Tell You if You’ve Already Had COVID-19?
Natalia Mesa | Aug 8, 2022
The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.
metallic-looking illustration of coronavirus structure
How the Omicron Subvariant BA.5 Became a Master of Disguise—and What It Means for the Current COVID-19 Surge
Suresh V. Kuchipudi, The Conversation | Jul 26, 2022
Several mechanisms contribute to the increased transmissibility of this SARS-CoV-2 variant.
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation
Identifying molecular targets for SARS-CoV-2 therapeutics.
Fluorescent cells in culture connected by tunneling nanotubules
SARS-CoV-2 Could Use Nanotubes to Infect the Brain
Natalia Mesa | Jul 21, 2022
Stressed cells can form hollow actin bridges to neighbors to get help, but the virus may hijack these tiny tunnels for its own purposes, a study suggests.